Nanalysis Scientific (CVE:NSCI) Shares Up 2.7%

Nanalysis Scientific Corp. (CVE:NSCI)’s share price shot up 2.7% during mid-day trading on Monday . The company traded as high as C$0.39 and last traded at C$0.38. 14,100 shares were traded during trading, a decline of 78% from the average session volume of 62,934 shares. The stock had previously closed at C$0.37.

Nanalysis Scientific Price Performance

The firm has a market cap of C$43.89 million, a price-to-earnings ratio of -2.18 and a beta of 0.82. The stock’s 50 day simple moving average is C$0.47 and its 200-day simple moving average is C$0.44. The company has a debt-to-equity ratio of 71.36, a quick ratio of 1.11 and a current ratio of 1.52.

Insider Buying and Selling at Nanalysis Scientific

In related news, Director Michal Okoniewski purchased 80,000 shares of the company’s stock in a transaction on Monday, March 18th. The stock was acquired at an average cost of C$0.38 per share, for a total transaction of C$30,400.00. Insiders own 7.11% of the company’s stock.

About Nanalysis Scientific

Nanalysis Scientific Corp. engages in the development, manufacture, and sale of magnetic resonance products in the United States, Canada, Europe, Asia, and internationally. The company operates through four segments: Nanalysis, RS2D, K'Prime, and Corporate. It offers nuclear magnetic resonance (NMR) spectrometers; software module packages; cutting-edge electronics components for precision analytical instruments; and services for its NMR technologies.